"The first attempt of plasma therapy on Covid-19 patient has proved successful at Sassoon hospital", the minister wrote on Twitter. The blood of a person who has recovered from Covid-19 develops antibodies to battle the virus.
The man said he has been informed that his plasma would be used to treat two critically-ill patients. The blood component that carries the antibodies can be collected and given to newly infected patients - it is known as "convalescent plasma". They had been admitted to Naidu Hospital along with their daughter, and had subsequently recovered and been discharged.
Mt. Sinai analysed outcomes for 39 hospitalised patients with severe COVID-19 who received convalescent plasma transfusions compared to outcomes for patients with carefully matched medical status. The plasma is then injected into an active Covid-19 patient to help kickstart the immune response.
"As of May 1, almost 13 per cent of plasma recipients had died, compared with more than 24 per cent of the control patients, with 72 per cent and 67 per cent, respectively, being discharged alive". As per the Indian Council of Medical Research (ICMR), hospitals and institutions planning to provide the treatment should do so using protocols that have been cleared by the Institutional Ethics Committee.
The new drug, an injection, which costs around Rs 20,000, will be given to 25 patients in the first phase and depending on the results, the Pune Municipal Corporation will decide on its further use, municipal commissioner Shekhar Gaikwad said.
According to hospital officials, the patient has been shifted out of COVID ward now as his reports came negative.
A bag containing blood plasma from a recovered Covid-19 patient.
Jets Do Not Plan To Trade Jamal Adams
While the Jets brass has emphasized the word voluntary, it seemed like Adams was attempting to send a message to the front office. Adams, 24, is due to make $3.5 million this year and is eligible for a contract extension as he has completed his third season.